CLINICAL EXPERIENCE WITH ETANERCEPT IN THE TREATMENT OF PATIENTS WITH ANKYLOSING SPONDYLITIS

Etanercept (ETC), a soluble tumor necrosis factor-α (TNF-α) receptor, was registered for the treatment of spondyloarthritis in the Russian Federation in 2009. By now, results of prolonged treatment with this drug have been obtained in patients with ankylosing spondylitis (AS).Objective: to evaluate...

Full description

Saved in:
Bibliographic Details
Main Authors: O. A. Rumyantseva, A. G. Bochkova, M. M. Urumova, T. V. Dubinina, Sh. F. Erdes
Format: Artigo
Language:Russo
Published: IMA-PRESS LLC 2018-05-01
Series:Научно-практическая ревматология
Subjects:
etanercept
ankylosing spondylitis
axial spondyloarthritis
remission
Online Access:https://rsp.mediar-press.net/rsp/article/view/2524
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items